Arabic Arabic English English French French German German

Discovery of key protein behind cancer relapse and progression can lead to new therapies

Reports show that cancer is the second-highest leading cause of death globally. A recent study by scientists provides new evidence supporting the presence of a key mechanism behind progression and relapse in cancer. The study discusses the role of MBNL1 protein as a biomarker for cancer prognosis, which can lead to the development of new treatment strategies for cancer.
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by HFACULTY News. Publisher: Top Health News — ScienceDaily Click this link to read the full content from the Publisher Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Promising therapy for cardiac regeneration

Next Post

Novel pathology could improve diagnosis and treatment of Huntington’s and other diseases

Related Posts